[go: up one dir, main page]

PL1778833T3 - Sposoby stosowania komórek regeneracyjnych w celu przyspieszania gojenia się ran - Google Patents

Sposoby stosowania komórek regeneracyjnych w celu przyspieszania gojenia się ran

Info

Publication number
PL1778833T3
PL1778833T3 PL04756623T PL04756623T PL1778833T3 PL 1778833 T3 PL1778833 T3 PL 1778833T3 PL 04756623 T PL04756623 T PL 04756623T PL 04756623 T PL04756623 T PL 04756623T PL 1778833 T3 PL1778833 T3 PL 1778833T3
Authority
PL
Poland
Prior art keywords
methods
adipose tissue
regenerative cells
wound healing
patient
Prior art date
Application number
PL04756623T
Other languages
English (en)
Inventor
Marc H Hedrick
John K Fraser
Eric Daniels
Original Assignee
Cytori Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytori Therapeutics Inc filed Critical Cytori Therapeutics Inc
Publication of PL1778833T3 publication Critical patent/PL1778833T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1384—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from adipose-derived stem cells [ADSC], from adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL04756623T 2004-07-01 2004-07-01 Sposoby stosowania komórek regeneracyjnych w celu przyspieszania gojenia się ran PL1778833T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04756623A EP1778833B1 (en) 2004-07-01 2004-07-01 Methods of using regenerative cells to promote wound healing
PCT/US2004/021415 WO2006014157A1 (en) 2004-07-01 2004-07-01 Methods of using regenerative cells to promote wound healing

Publications (1)

Publication Number Publication Date
PL1778833T3 true PL1778833T3 (pl) 2011-10-31

Family

ID=35787384

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04756623T PL1778833T3 (pl) 2004-07-01 2004-07-01 Sposoby stosowania komórek regeneracyjnych w celu przyspieszania gojenia się ran

Country Status (11)

Country Link
EP (2) EP2332555A3 (pl)
JP (1) JP4733699B2 (pl)
KR (1) KR101197909B1 (pl)
CN (1) CN101031639A (pl)
AT (1) ATE501247T1 (pl)
CA (1) CA2572113C (pl)
DE (1) DE602004031782D1 (pl)
DK (1) DK1778833T3 (pl)
ES (1) ES2364957T3 (pl)
PL (1) PL1778833T3 (pl)
WO (1) WO2006014157A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9144583B2 (en) 2002-03-29 2015-09-29 Tissue Genesis, Inc. Cell separation apparatus and methods of use
FR2902011B1 (fr) * 2006-06-12 2008-12-26 Inst Radioprot Et De Surete Nu Utilisation de fractions cellulaires du tissu adipeux pour la regeneration tissulaire post irradiation
WO2008060374A2 (en) 2006-10-06 2008-05-22 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
JP5038336B2 (ja) * 2007-02-16 2012-10-03 オリンパス株式会社 脂肪消化終了判定装置および脂肪組織消化装置
US11174458B2 (en) 2007-04-23 2021-11-16 Koligo Therapeutics, Inc. Cell separation apparatus and methods of use
WO2014178438A1 (ja) * 2013-05-02 2014-11-06 Saeki Masanori 毛髪再生用の細胞製剤
US9580678B2 (en) 2013-06-21 2017-02-28 The Regents Of The University Of California Microfluidic tumor tissue dissociation device
WO2015149098A1 (de) 2014-03-31 2015-10-08 Liporegena Gmbh Vorrichtung zur entnahme und portionierung von fettgewebe
CN111773173B (zh) * 2014-11-07 2024-03-22 胞外体干细胞株式会社 用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物
CN104814788A (zh) * 2015-03-21 2015-08-05 李玉欣 外科整形治疗装置
US10722540B1 (en) 2016-02-01 2020-07-28 The Regents Of The University Of California Microfluidic device and method for shear stress-induced transformation of cells
CN109564231B (zh) 2016-06-08 2023-01-06 加利福尼亚大学董事会 用于处理组织和细胞的方法和装置
CN106177920A (zh) * 2016-07-28 2016-12-07 广州赛莱拉干细胞科技股份有限公司 一种促进伤口愈合的脂肪组织制剂及其制备方法
CN106177919A (zh) * 2016-07-28 2016-12-07 广州赛莱拉干细胞科技股份有限公司 一种改善伤口愈合的脂肪制剂及其制备方法
CN106177910A (zh) * 2016-07-28 2016-12-07 广州赛莱拉干细胞科技股份有限公司 一种促进伤口愈合的脂肪组织制剂及其制备方法
CN106215172A (zh) * 2016-07-28 2016-12-14 广州赛莱拉干细胞科技股份有限公司 一种改善伤口愈合的脂肪制剂及其制备方法
CN108635376A (zh) * 2018-04-09 2018-10-12 孔五 脐带血再生粒子及其组合物在治疗皮肤伤口愈合中的用途
WO2020014298A1 (en) * 2018-07-10 2020-01-16 Rush University Medical Center Use of immunomodulators to control infection and stimulate healing in normal and diabetic wounds
CN110755609A (zh) * 2018-07-27 2020-02-07 上海微创医疗器械（集团）有限公司 一种特异性抗体的用途、一种植入医疗器械及其制备方法
CN109176186B (zh) * 2018-11-02 2023-09-26 江苏康宏医疗科技有限公司 止血钳、活检钳、异物钳的弹簧软管自动切线、打磨装置

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5092883A (en) * 1988-12-28 1992-03-03 Eppley Barry L Method for promoting soft connective tissue growth and repair in mammals
US6238908B1 (en) 1995-06-07 2001-05-29 Aastrom Biosciences, Inc. Apparatus and method for maintaining and growth biological cells
FR2742662B1 (fr) 1995-12-21 1998-01-23 Centre Nat Rech Scient Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments
US6280473B1 (en) 1996-08-19 2001-08-28 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US5919234A (en) 1996-08-19 1999-07-06 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US6269716B1 (en) 1998-11-18 2001-08-07 Macropore, Inc. High-torque resorbable screws
DE69923167T2 (de) 1998-04-07 2006-01-12 Macropore, Inc., San Diego Membran mit gewellter Oberfläche zur Führung des Gewebes
US6001642A (en) 1998-06-29 1999-12-14 Wyle Laboratories, Inc. Life Sciences Bioreactor and cell culturing processes using the bioreactor
WO2001036663A2 (en) 1999-11-15 2001-05-25 Chemclean Corporation Bio-burden visualization system
MXPA02008897A (es) 2000-03-10 2004-10-14 Macropore Inc Micro-membranas barrera reabsorbibles para atenuacion de tejido de cicatriz durante sanado.
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
US6635064B2 (en) 2000-10-04 2003-10-21 Macropore Biosurgery, Inc. Non-scatterable, radio-opaque material for medical imaging applications
JP4680483B2 (ja) * 2001-02-23 2011-05-11 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 組織および臓器の治療および修復に用いるための幹細胞マトリックスの迅速な調製方法
EP1892289A3 (en) * 2001-11-09 2008-03-05 Artecel Sciences, Inc. Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
CA2849201A1 (en) 2001-12-07 2003-07-03 Macropore Biosurgery, Inc. Adipose-derived cell processing unit
AU2004260937B2 (en) * 2003-06-25 2010-05-13 Macropore Biosurgery Inc. Systems and methods for separating and concentrating regenerative cells from tissue

Also Published As

Publication number Publication date
JP4733699B2 (ja) 2011-07-27
CA2572113C (en) 2017-04-18
CA2572113A1 (en) 2006-02-09
DE602004031782D1 (de) 2011-04-21
WO2006014157A1 (en) 2006-02-09
EP1778833B1 (en) 2011-03-09
EP2332555A2 (en) 2011-06-15
EP1778833A4 (en) 2007-11-07
ES2364957T3 (es) 2011-09-19
JP2008505072A (ja) 2008-02-21
ATE501247T1 (de) 2011-03-15
EP1778833A1 (en) 2007-05-02
EP2332555A3 (en) 2011-06-29
KR20070038538A (ko) 2007-04-10
WO2006014157A9 (en) 2007-03-08
DK1778833T3 (da) 2011-06-27
KR101197909B1 (ko) 2012-11-06
CN101031639A (zh) 2007-09-05

Similar Documents

Publication Publication Date Title
PL1778833T3 (pl) Sposoby stosowania komórek regeneracyjnych w celu przyspieszania gojenia się ran
PL1885382T3 (pl) Sposoby stosowania komórek pochodzących z tkanki tłuszczowej w leczeniu stanów układu sercowo-naczyniowego
HK1102085A1 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
EP2305276A3 (en) Processed lipoaspirate cells for use in therapy
MX2008013304A (es) Compuestos de peptido 1 tipo glucagon.
MX2019005300A (es) Polimeros enlazados al proton para administracion oral.
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
DE60334740D1 (de) Vorrichtung zur interstitiellen laserbehandlungvon kleinen brustkrebsgeschwülsten und damit verbundene therapie
MX2010004350A (es) Metodos de uso del acido (+)-1,4-dihidro-7-[(3s,4s)]-3-metoxi-4-(m etilamino)-1-pirrolidinil-4-oxo-1-(2-tiazolil)-1, 8-naftiridina-3-carboxilico en terapias de combinacion.
TW200630089A (en) Treatment methods
WO2006014162A3 (en) Methods of using regenerative cells in the treatment of renal diseases and disorders
TW200724189A (en) Method of and system for predicting dose delivery
CN104721967A (zh) 治疗脚气用紫外线治疗仪
UA29731U (ru) Способ лечения больных с легкой черепно-мозговой травмой по методу е.в. зубковой и и.з. самосюка
UA6522U (en) Method for treating patients with multiple and combined injuries of long bones
UA43828U (ru) Способ лечения поражения правого желудочка у больных инфарктом миокарда задней стенки левого желудочка
UA37078U (ru) Способ профилактики рефлюкс-холангита при хирургическом лечении больных с механической желтухой
UA97642U (uk) Спосіб лікування хворих на виразкову хворобу дванадцятипалої кишки в сумісності з ішемічною хворобою серця
UA106674U (uk) Спосіб лікування хворих на анкілозуючий спондилоартрит
UA4292U (uk) Спосіб лікування альвеолітів